Inventor · disambiguated record
James Douglas Griffin
Also filed as: GRIFFIN JAMES · GRIFFIN JAMES D · GRIFFIN JAMES DOUGLAS
12 granted patents·12 pending applications·385 citations·filing 1987–2022
92Inventor score
Files withDANA FARBER CANCER INST INC9GRIFFIN JAMES DOUGLAS8LIN BORIS2GILLILAND D G1GILLILAND D GARY1
Top patents by PatentIndex Score
24 records- 0190US5019648AMonoclonal antibody specific for the adhesion function domain of a phagocyte cell surface proteinDANA FARBER CANCER INST INC·Filed 1988·Granted May 28, 1991·82 cites·9 claims
- 0288US4935234AMethod of reducing tissue damage at an inflammatory site using a monoclonal antibodyDANA FARBER CANCER INST INC·Filed 1988·Granted Jun 19, 1990·115 cites·10 claims
- 0387US4840793AMethod of reducing tissue damage at an inflammatory site using a monoclonal antibodyDANA FARBER CANCER INST INC·Filed 1987·Granted Jun 20, 1989·113 cites·11 claims
- 0484US10155987B2Methods of predicting resistance to JAK inhibitor therapyDANA FARBER CANCER INST INC·Filed 2013·Granted Dec 18, 2018·9 cites·11 claims
- 0583US11136409B2Compositions and methods for identification, assessment, prevention, and treatment of AML using USP10 biomarkers and modulatorsDANA FARBER CANCER INST INC·Filed 2017·Granted Oct 5, 2021·2 cites·8 claims
- 0677US7973031B2Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activityNOVARTIS AG·Filed 2002·Granted Jul 5, 2011·7 cites·6 claims
- 0776US8492429B2Combination of IAP inhibitors and FLT3 inhibitorsGRIFFIN JAMES DOUGLAS·Filed 2007·Granted Jul 23, 2013·3 cites·6 claims
- 0876US8222244B2Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activityGRIFFIN JAMES D·Filed 2011·Granted Jul 17, 2012·4 cites·6 claims
- 0970US5219997AMonoclonal antibody which inhibits the adhesion functions of the β integrin, CR3DANA FARBER CANCER INST INC·Filed 1991·Granted Jun 15, 1993·27 cites·1 claims
- 1070US4931395AMonoclonal antibody specific to neutrophilsDANA FARBER CANCER INST INC·Filed 1987·Granted Jun 5, 1990·23 cites·10 claims
- 1170US2009233973A1Epothilone derivatives for the treatment of multiple myelomaLIN BORIS·Filed 2009·Application pending·0 cites
- 1269US2014303146A1Method of Treating Mixed Lineage Leukemia Gene-Rearranged Acute Lymphoblastic LeukemiasGRIFFIN JAMES DOUGLAS·Filed 2014·Application pending·0 cites
- 1367US2014057897A1Method of treating mixed lineage leukemia gene-rearranged acute lymphoblastic leukemiasGRIFFIN JAMES DOUGLAS·Filed 2013·Application pending·0 cites
- 1464US2012329779A1Method of Treating Mixed Lineage Leukemia Gene-Rearranged Acute Lymphoblastic LeukemiasGRIFFIN JAMES DOUGLAS·Filed 2012·Application pending·0 cites
- 1559US2011009383A1Method of treating mixed lineage leukemia gene-rearranged acute lymphoblastic leukemiasGRIFFIN JAMES DOUGLAS·Filed 2010·Application pending·0 cites
- 1658US9700565B2Method of treating mixed lineage leukemia gene-rearranged acute lymphoblastic leukemiasGRIFFIN JAMES DOUGLAS·Filed 2015·Granted Jul 11, 2017·0 cites·3 claims
- 1758US2006094766A1Epothilone derivatives for the treatment of multiple myelomaLIN BORIS·Filed 2003·Application pending·0 cites
- 1857US2024335427A1Small molecule inhibition of deubiquitinating enzyme josephin domain containing 1 (josd1) as a targeted therapy for leukemias with mutant janus kinase 2 (jak2)DANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 1956US8445479B2Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activityGRIFFIN JAMES DOUGLAS·Filed 2012·Granted May 21, 2013·0 cites·7 claims
- 2054US2008221080A1Method of Treating Mixed Lineage Leukemia Gene-Rearranged Acute Lymphoblastic LeukemiasGRIFFIN JAMES DOUGLAS·Filed 2003·Application pending·0 cites
- 2151US2006229290A1Staurosporine derivatives for hypereosinophilic syndromeGILLILAND D G·Filed 2004·Application pending·0 cites
- 2248US2023113802A1Composition and method to prepare long-acting injectable suspension containing multiple cancer drugsUNIV WASHINGTON·Filed 2021·Application pending·0 cites
- 2343US2014243396A1Method of treating mucoepidermoid carcinomaDANA FARBER CANCER INST INC·Filed 2012·Application pending·0 cites
- 2442US2009286770A1Use of Staurosporine Derivatives for the Treatment of Multiple MyelomaGILLILAND D GARY·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James Douglas Griffin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →